Home/Filings/4/0001213900-24-047094
4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-24-047094

CIK 0001728328other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 4:26 PM ET

Size

5.5 KB

Accession

0001213900-24-047094

Insider Transaction Report

Form 4
Period: 2024-05-27
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2024-05-271,139161,000 total
    Exercise: $263.18From: 2019-05-27Exp: 2024-05-27Common shares (1,139 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817882

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:26 PM ET
Size
5.5 KB